Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Does it matter? There was only $3000 or so traded today.
Sorry, a little to young to remember that show.
I do agree with your assessment of the Indian sale vs. the UAE and Russian sale. It does appear to be an acutal retail sale and therefore they should be used pretty quickly (depending on quantity). So a follow up order could be pending shortly if of course they are happy with the results and feedback from the military. Yes, an amount would be nice to know...we should have an idea based off the 10Q in mid May. As far as your last statement, you seem to implying Roger is a Rat and I won't agree to that. A little to harsh for me. If somehow the SFDA has got back on track to follow time lines, the last portion was given 40 business days. This does not account for the 20 days the Technical committee has to file and send the approval notice to the final committee (Not sure if that had been done or not...assuming yes). So hopefully we could have a result by the end of March.
I'll try to balance your post out with some positives since Roger has taken over at the helm:
-Aware BSP approved for USAID (really inconsiquential)
-Aware OMT approved for USAID
-First Sales into the UAE
-Aware OMT test approved and first sales into Russia
-Opened local offices in MENA and Geneva
-Has successfully been able to raise money in order to keep the Company afloat
-Has begun a U.S. initiative (opened new office and manufacturing facility in Portland)
-Indian approval and initial sales
Post Script: I am upset with Calypte's faulty projections and I'm sure the company knows most investors are as well. For that reason, I think Roger will be extremely careful from here on out with his projections and forward looking statements. Notice there was no mention of additional sales (goals, projections, plans, etc.) into India, unlike early PRs with sales into UAE, Russia, and SA(Mineseeker). This is fine with me...I would rather feel pleasently surprised than greatly unsatified -- as I have thus far.
Thank you for the discussion Blood, no one else here seems to have to much to add. Have you seen Linda on any of the other boards you use? Wonder where she's at.
Thanks for the response. You are correct that India was having issues with substandarded HIV test, most of the tests did not go through any prequalification or approval process. As far as I know, these were not OMT tests but blood tests.
?????
Still no response, what were you talking about?
Explain. I listed facts and a "possible" scenario. I don't think there are any facts that rule out this possibility.
Hey Viz,
Its best to just engage into a discussion with them (at least the intelligent ones (Blood)). He brings up a lot of good points and is usually willing to admit when he is wrong. I would rather have someone post negative things about the company (that are true of course) than someone post untrue postivie pumping posts. This board lacks any real discussion, which I try to provide. Please VIZ provide us with some thoughts.
Please explain...Paraphrasing your statement "India embraced one rapid oral test already and it didn't work out"
I'm confused..India already tried this approach? What test (orasure)?
Thank god for CEOcast...their weekly newsletter has created such a frenzy that CMBC traded a whole $6500 worth of shares today!!!
No comments on my link to AIDS/HIV and the Indian Military?
From the article, "The spread of HIV in India’s huge armed forces, (with 1.3 million active military personnel, 535,000 reserve force members, and another 1.3 million in paramilitary forces,) is occurring despite force-wide HIV screening introduced in 2006."
So we are looking at three million or so soldiers, not including the testing of new recruits, etc. Let's say the initial sale (mostly likely only 10,000, maybe even less) is very well adapted to (the testers like it, the soldiers like it). The government believes the payoff is worth the extra cost and want to implement oral testing for at least 50% of all testing (since Calypte has the only approved oral test - this would constitue all the tests would have to come from Calypte). We could calculate 1.5 million soldiers to be tested (it is mandatory) perhaps 2 times a year. That is 3 million test that could be sold (sales of 5 million approx) just to one half of one country's military forces.
Just a thought...there is one problem though - Calypte has never shown the ability to land sales of any significant size. Again with the potential, but not the delivery.
"Due to inquiries in US by people who have bought Calypte's BED incidence test (their only US customers), Calypte has developed an oral collection device to send oral fluid to labs to be tested (by Orasure in US?)."
The part a refute is the Orasure part. I think you are under the assumption this is strickly for HIV. These swabs can be used for any Antibody collection - Drug testing, DNA collection, etc.
I have no idea why the CDC would be requesting such a product. To be honest, I did not even know a market for such a device even exisited. My point was to only reject Bloods implied claim that Calypte had no U.S. customers, when in fact they do.
As far as the possibilites for this product, I'll give one example that immediately comes to mind: Drug Testing. Imagine a company that employes 500 workers. They call 20 in at a time for 15-20 seconds, have them brush their gums with the device and collect all 500 samples. They can get all the samples within half an hour or so. They then mail them in to a lab and get the results within a couple days. The benefit in being that it keeps employees out of work for only a minute or two and removes urine from the equation.
Do I think this is a revolutionary product? No
Do I think this product will amount to any surmountable sales? No
I do however think it is a descent supplement to their product line.
I have always been a realist when it comes to this company and stock, please do not take me anyother way SellHigh.
Did I say it was?
My thought is the U.S. Customer is the CDC which uses Calypte's BED Incidence test. They may be looking for a collection device of this stature.
lose/lose deal for Calypte?
How so? These deals are very popular amongst small bio-tech companies that need funding. The shares upfront are a fee for an agreement that could produce upwards of $8 million dollars in funding for the company. This type of funding puts the control in the hands of Calypte and is very flexible. Calypte has the ability to sell stock when it feels necessary and allows them to use the proceeds as needed. The stock will never be sold at a reduced/discounted price to Fusion, but sold at current market price. There is still obvious risk involved for Fusion and is really a must need (and therefore will say 'win') for the Company. Is it a win for shareholders though? Time will tell that....more time (seems like a never ending story here)
BTW - I thought you were leaving the message boards alone for while? Couldn't keep away huh? So sad...We should all have an intervention for you.
The shares were never exercised, we know that.
1. "They have some shares registered for sale. Holding over a 100 million shares now that they are unable to sell yet. Why add more now?" ---> Well,the company needs the money! 100 million shares at $0 still equals $0. If they are willing to exercise some warrants it may create enough cash for Calypte to finally become an actual entity that makes money and will therefore raise share price. Of course the additional shares/cost add more risk. My guess is they haven't quite heard what they've wanted to hear from Roger and the gang. My Opinion only.
Wow, this board is dead in 08. I was hoping for at least some consistant discussion. Any one with any thoughts on why the 07 PIPE investors haven't exercised their shares?
http://slimconomy.blogspot.com/
Notice when speaking of MedMira:
"They recently hired a new senior sales guy, much needed, but he comes from Calypte who hasn’t had a stellar past; but then neither are their products. So perhaps he can turn it around with MedMira's good products"
The new hire is Richard "Dick" Van Maanen.
Say what you will, but I was a buyer again today at .091. I think this news may be more significant then the market's reaction. If you note this permit was given directly from the SDFA. It allows the company, not to manufacture for export, but to manufacture the test directly into domestic China. While I'm sure this is a different department than those that actually approve the test, It would make sense that some communication between the departments is going on. If they are willing to grant this permit for production into the country, it seems as though the next logical step would be for approval. Why give a permit to manufacture something you don't want to or won't approve?
I think the approval will come within the next three months. As we all know, an approval doesn't not lead to sales. However, the approval should give a nice pop to the stock price.
JMO
Sorry to hear of your loss. As much as we all bump heads here at times, I think death sometimes can really put things into perspective and makes one realize what is truly important in life. PS - Its not money.
That's not funny, its just the truth. What's funny is that you care so much, and even that is more sad than funny.
I do believe that some of these posters do have unmentioned vested interests here, but that does not mean they are incorrect and does not explain why Calypte can't gain any market share.
I do believe news of SFDA approval will significantly increase the price of this stock (whether deserved or not).
I understand your frustration. I don't think we'll see any more projections out of this company. The market they are trying to penetrate is just too difficult to predict. I am keeping my shares and will continue to buy as the stock price decreases. Its a gamble I'm willing to take. I do believe they can reach break even by the end of 2008.
Hey Blood, Wow Calypte is actually talking! Looks like you are getting some answers so we won't have to keep listening to you ask them.
Anyone hearing anything? -- Never Mind, Its on now
Don't worry blood, I sent in some questions...some of which were on your list. I'm for one thankful for Calytpe doing this. I was not expecting it. I hope others will be sending in some questions.
P.S. I think the formal portion will just be the voting and wouldn't really be worth setting a conference call for. The results will be made aware to us at some point.
I really think the entire process has been put on the back burner by the SFDA. My main concern is that the Chinese officials have communicated something to Calypte directors and they have not informed us because it was negative.
Of course they could. I didn't mean to say 'one day' is an absolute time to report material events. They just can't be buying shares based on information before it is announced to shareholders.
Announcements can be made during the shareholder meeting. An 8K would need to be filed to account for any new updates that were stated during the meeting. If they are currently aware of a material event, then yes that information should be made public within a day of recieving notice of such an event.
Please send an email asking these questions to:
rgale@calypte.com
jdottson@calypte.com
I have sent previous emails. If enough shareholders send emails/make phone calls, the more likely they will provide us with some information during the shareholder meeting tomorrow. I am hoping for some information to be announced during the meeting, followed by a filing.
Not sure where you got "David" from, its Daniel and no this would not be R. Brounstein's replacement.
http://phx.corporate-ir.net/phoenix.zhtml?c=97535&p=irol-newsArticle&ID=1038114&highlight=
Where's your big announcement for World Aids Day?
The average cost of an HIV rapid test in North America is between 12 and 15 dollars being sold to hospitals, etc. I don't thing it would be that far fetched to say the average cost of these tests would be 20 each. This would equal a total of 3 million a year just in Incidence tests.
Please do not take the 20 dollar per test as the truth, I really don't have any idea. Just speculating.
The estimated volume of tests per year is 150,000.
What are the costs of these test I wonder.
New Estitmates from the one Analyst:
Revenue Est
Qtr Dec 07 - 190.00K
Qtr Mar08 - 450.00K
Year Dec07 - 660.00K
Year Dec08 - 5.43M
Will you be attending the Annual shareholder meeting?
World AIDS Day Events 2007
Public Testing Campaign
Monday, November 26th, 10:00am-12:00pm – Nairobi, Kenya
Kenyan private sector leaders will come together in Nairobi Monday to take part in a public testing and counseling campaign to support voluntary counseling and testing (VCT) in the East African nation. The event, in which business leaders will get tested publicly, aims to leverage the private sector’s power and influence in order to reinforce the message that knowing one’s HIV status is empowering. Currently, only 2 million of Kenya’s 35 million citizens have been tested for HIV.
For more information, contact: Julie Cege, jcege@businessfightsaids.org